Thrive Therapies Group Raises $7.7M Series A Led by LiveOak Ventures

Thrive Therapies Group, a Nashville-based healthcare and EdTech company serving K-12 special education, has raised a $7.7 million Series A round. LiveOak Ventures led the round, with participation from Activate Venture Partners and Charter School Growth Fund.

What the Company Does

Thrive Therapies Group builds software and delivers clinical services for special education in K-12 public schools. The company is women-founded and based in Nashville.

Its platform spans a broad set of special education workflows:

• AI-generated session notes
• Smart diagnostics
• IEP case management
• Evaluation and report-writing tools
• EMR and Medicaid billing
• Outcome analytics

Alongside the software, Thrive provides school-based related services, including speech, occupational and physical therapy, mental-health services and nursing staffing.

Reported Outcomes

According to the company, its platform saves providers roughly 10 hours per week and schools about $570 per student. Thrive Therapies Group also won the Nashville Entrepreneur Center NEXT Award as Healthcare Startup of the Year in 2023.

The Round at a Glance

• Company: Thrive Therapies Group
• Round: Series A
• Amount: $7.7 million (USD)
• Lead investor: LiveOak Ventures
• Additional investors: Activate Venture Partners, Charter School Growth Fund
• Sector: Healthcare and EdTech software plus clinical services for K-12 special education

Why It Matters for Acquisition Watchers

The round sits at the intersection of two markets that strategic buyers have tracked closely: school-based clinical services and special education software. Thrive combines both in a single operating model, pairing a staffing and services business with a software platform that addresses documentation, billing and compliance workflows.

That combination can be attractive for acquirers looking at either healthcare services roll-ups or education technology consolidation. The services arm provides direct school relationships and recurring revenue, while the platform offers software economics and data on outcomes. The participation of Charter School Growth Fund alongside traditional venture investors reflects interest from the education-focused segment of the market.

The Series A gives the company fresh capital at a defined stage, with a lead investor in LiveOak Ventures and a syndicate that includes both healthcare-adjacent and education-focused backers. For parties monitoring the K-12 special education and school-based therapy space, Thrive Therapies Group is now a funded player with a stated platform and a set of reported efficiency gains for providers and schools.